Featured Research

from universities, journals, and other organizations

Neuroscientists learn how channels fine-tune neuronal excitability

Date:
January 26, 2011
Source:
University of Calgary
Summary:
Scientists have discovered a new mechanism that nerve cells (neurons) use to fine-tune their electrical output. The discovery provides new insights about how the activity of the nervous system is regulated at the cellular level

Scientists in the Hotchkiss Brain Institute at the Faculty of Medicine, University of Calgary, have discovered a new mechanism that nerve cells (neurons) use to fine-tune their electrical output. The discovery, published in the journal Nature Neuroscience, provides new insights about how the activity of the nervous system is regulated at the cellular level.

Nerve cells in our nervous system use electrical impulses to transmit signals throughout our body. One way that they do this is through the trafficking of calcium channels through to the outer surface (plasma membrane) of the cell. Calcium entry into a neuron through a calcium channel is a critical first step in allowing communication between neurons.

HBI researchers Gerald Zamponi Ph.D., Christophe Altier Ph.D. and Agustin Garcia-Caballero Ph.D. study how calcium channels, and the proteins that associate with them, help control nerve cell activity. They explored how one such protein, the beta subunit, can act as a regulatory mechanism for the 'L-type' calcium channel. These channels play an important role in the proper functioning of nerve, muscle, and cardiac pacemaker cells, but when the channels are overactive this has negative consequences that can give rise to conditions such as autism and hypertension.

The new finding adds significantly to our understanding of calcium channel function in health and disease, including several debilitating conditions. "The abnormal regulation of 'L-type' calcium channels has been linked to conditions such as epilepsy, cardiac arrhythmia and chronic pain" says Altier, "and so understanding the role of regulatory influences such as the beta subunit will be an important part of treating these diseases."

These channels control when, where and how much calcium is allowed to enter the cell, determining not only that cell's 'electrical' response, but also its ability to regulate gene expression and other cellular functions. They achieve this fine balance in numerous ways, including by associating with auxiliary proteins such as the calcium channel beta subunit. Researchers know the beta subunit can regulate the number of calcium channels on the membrane of a cell but until now, it wasn't known how it achieved this effect.

In their paper, Zamponi and colleagues reveal the mechanism by which the beta subunit regulates 'L-type' calcium channel movement. They show that the beta subunit stabilizes the channel and blocks a site that would otherwise mark the channel for removal and degradation, a process called endoplasmic reticulum-associated protein degradation (ERAD).

"The beta subunit essentially acts as a molecular switch," says Zamponi, Head of the Department of Physiology & Pharmacology, "it determines the fate of the channels by controlling where they end up and therefore if they can let calcium into the cell or not."

Zamponi believes that revealing the mechanism by which the beta subunit regulates sorting and trafficking of 'L-type' calcium channels will highlight fundamental regulatory mechanisms that are common in other calcium channel types.


Story Source:

The above story is based on materials provided by University of Calgary. Note: Materials may be edited for content and length.


Journal Reference:

  1. Christophe Altier, Agustin Garcia-Caballero, Brett Simms, Haitao You, Lina Chen, Jan Walcher, H William Tedford, Tamara Hermosilla, Gerald W Zamponi. The Cavβ subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels. Nature Neuroscience, 2010; DOI: 10.1038/nn.2712

Cite This Page:

University of Calgary. "Neuroscientists learn how channels fine-tune neuronal excitability." ScienceDaily. ScienceDaily, 26 January 2011. <www.sciencedaily.com/releases/2011/01/110126091439.htm>.
University of Calgary. (2011, January 26). Neuroscientists learn how channels fine-tune neuronal excitability. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/01/110126091439.htm
University of Calgary. "Neuroscientists learn how channels fine-tune neuronal excitability." ScienceDaily. www.sciencedaily.com/releases/2011/01/110126091439.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins